Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2009, p. 4911-4914, Vol. 53, No. 11
0066-4804/09/$08.00+0 doi:10.1128/AAC.00703-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Mycoplasma Unit, Division of Avian and Aquatic Diseases, Kimron Veterinary Institute, Bet Dagan, Israel
Received 26 May 2009/ Returned for modification 10 July 2009/ Accepted 22 August 2009
Comparison of the quinolone resistance-determining regions (QRDRs) in 42 Mycoplasma bovis clinical isolates revealed amino acid substitutions at both GyrA (position 83) and ParC (position 84) in 10/11 enrofloxacin-resistant strains. The mutation present in the parC QRDR was discriminative for enrofloxacin resistance by parC PCR-restriction fragment length polymorphism. Comparison of molecular profiles by insertion sequence typing suggests that the currently prevalent enrofloxacin-resistant M. bovis strain evolved by selection under field conditions from one of the susceptible strains.
Published ahead of print on 31 August 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»